Hemab Therapeutics Holdings, Inc. - Common Stock, par value $0.001 per share (COAG)

CUSIP: 423494103

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 5 signals
Share change
+36,183,003
SEC-reported price per share
$36.73
Number of holders
55
Value change
+$1,329,008,078
Number of buys
55
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
46,717,224

Security key

423494103

Report period

Q2 2026

Institutions

55

Top holders

10

Ownership snapshot

Top reported holders of COAG - Hemab Therapeutics Holdings, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
5/15
Latest evidence
30 Jun 2026
13D/G 3/4/5 Lead comparable stake: 9% 10 rows are not safely comparable across share classes. 13D/G row: Novo Holdings A/S Showing 1-6 of 15 holder rows.

Quick read

Novo Holdings A/S leads the comparable SEC ownership view at 9%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Novo Holdings A/S's linked filing trail.
Comparable ownership Top 5
Novo Holdings A/S 9%
FMR LLC 7.9%
Capital International Investors 7.7%
Avoro Capital Advisors LLC 7.1%
Sofinnova Crossover II S.L.P. 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Novo Holdings A/S
13D/G 3/4/5
10%+ Owner
9%
$165,173,530
4,180,550 shares
$0 30 Jun 2026
FMR LLC
13D/G
7.9%
$146,101,540
3,697,837 shares
$0 30 Jun 2026
Capital International Investors
13D/G
7.7%
$142,389,141
3,603,876 shares
$0 30 Jun 2026
Avoro Capital Advisors LLC
13D/G
Behzad Aghazadeh
7.1%
$130,313,304
3,298,236 shares
$0 30 Jun 2026
Sofinnova Crossover II S.L.P.
13D/G
Sofinnova Crossover II SLP
5.4%
$99,217,986
2,511,212 shares
$0 30 Jun 2026
Peter Kolchinsky
3/4/5
10%+ Owner
class O/S missing
$160,987,032
6,444,637 shares
+$1,689,818 15 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
55
Shares
36,183,003
Rows available
55
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
0
Q2 2026 holders
55
Holder diff
55
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .